PITTSBURGH, Sept. 19, 2025 /PRNewswire/ –Allegheny Health Network’s (AHN) Allegheny General Hospital (AGH) is once again…
Category: News
AOFAS Annual Meeting 2025 Highlights Advancements and Innovation in Orthopaedics
Leaders Recognized for Contributions to Foot and Ankle Orthopaedics SCHAUMBURG, Ill., Sept. 19, 2025 /PRNewswire/ –More…
CVS Pharmacy celebrates reopening of Pacific Palisades store damaged by devastating wildfires
The Swarthmore Avenue CVS Pharmacy is the first community pharmacy to reopen in the neighborhood, increasing…
Kansas City Royals and Sun Life raise $50,000 for Boys & Girls Clubs of Greater Kansas City through Strikeout Diabetes campaign
KANSAS CITY,Mo., Sept. 19, 2025 /PRNewswire/ — Teaming up for the eighth year, Sun Life U.S.…
Honoring organ donors and inspiring hope for those waiting for transplants, the Fresno Stride for Hope Run/Walk returns Saturday, Sept. 20
The Central Valley community is invited to join the 5K fundraiser to enhance essential programs and…
Olympus Issues Voluntary Recall for Specific Lots of ViziShot 2 FLEX (19G) EBUS -TBNA Needles
CENTER VALLEY, Pa., Sept. 19, 2025 /PRNewswire/ –Olympus Corporation has announced a voluntary, global medical device…
TREMFYA® (guselkumab) achieves U.S. approval for subcutaneous induction in adults with ulcerative colitis, now the first and only IL-23 inhibitor with a fully subcutaneous regimen
TREMFYA® offers the flexibility of self-administration from the start of treatment, building on the prior approval…
三获艾美奖的记者Gaby Natale推出Menopausia.com
三获艾美奖记者Gaby Natale推出Menopausia.com：首个专为经历更年期与围绝经期女性打造的双语平台 先锋企业家以科学、社区与商业打破沉寂，将中年与长寿重新定义为生命绽放的黄金阶段。 达拉斯2025年9月19日 /美通社/ — 三获艾美奖的记者、畅销书作家及全球知名主题演讲者Gaby Natale正式推出Menopausia.com——首个致力于帮助女性度过更年期与围绝经期各阶段的双语数字平台。 在健康、科技和文化变革的交汇点，Menopausia.com不仅仅是一个平台，更是我们如何经历中年期的文化重塑。 该平台专为预计到2030年将进入更年期的12亿女性打造，提供专家主导的内容、支持症状检索的解决方案和严选商品专区——所有服务均以英语和西班牙语双语提供。 三获艾美奖的记者、演讲者和Menopausia.com创始人Gaby Natale “这并非又一个健康网站而已。 这是我多年前发现的市场空白——一个能让科学、女性情谊与叙事力量相互交融，从而重新定义中年人生的领域。”Gaby Natale表示。 “作为一位在四十多岁经历医学诱导更年期的癌症幸存者，我深切理解女性在这个人生阶段所感受到的隐形困境。…
Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ –Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a commercial-stage biotechnology…
Médicos internacionales visitan la sede de Smartee
– Médicos internacionales visitan la sede de Smartee y comparten conocimientos sobre ortodoncia de última generación…